89bio, Inc.·4

Sep 20, 4:32 PM ET

Waisbourd Ram 4

4 · 89bio, Inc. · Filed Sep 20, 2021

Insider Transaction Report

Form 4
Period: 2021-09-16
Waisbourd Ram
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2021-09-16$1.93/sh+7,000$13,5107,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-09-167,00025,203 total
    Exercise: $1.93Exp: 2028-11-09Common Stock (7,000 underlying)
  • Sale

    Common Stock

    2021-09-16$19.46/sh7,000$136,2200 total
Footnotes (2)
  • [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $19.18 to $20.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION